Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

NNOX vs DBVT vs ALKS vs HOLO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
NNOX
Nano-X Imaging Ltd.

Medical - Devices

HealthcareNASDAQ • IL
Market Cap$115M
5Y Perf.-93.0%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.-64.5%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.90B
5Y Perf.+7.8%
HOLO
MicroCloud Hologram Inc.

Hardware, Equipment & Parts

TechnologyNASDAQ • CN
Market Cap$3M
5Y Perf.-100.0%

NNOX vs DBVT vs ALKS vs HOLO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
NNOX logoNNOX
DBVT logoDBVT
ALKS logoALKS
HOLO logoHOLO
IndustryMedical - DevicesBiotechnologyBiotechnologyHardware, Equipment & Parts
Market Cap$115M$1712.35T$5.90B$3M
Revenue (TTM)$12M$0.00$1.56B$321M
Net Income (TTM)$-56M$-168M$153M$295M
Gross Margin-98.8%65.4%24.2%
Operating Margin-469.7%12.3%-1.1%
Forward P/E24.8x
Total Debt$7M$22M$70M$8M
Cash & Equiv.$39M$194M$1.12B$851M

NNOX vs DBVT vs ALKS vs HOLOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

NNOX
DBVT
ALKS
HOLO
StockAug 21May 26Return
Nano-X Imaging Ltd. (NNOX)1007.0-93.0%
DBV Technologies S.… (DBVT)10035.5-64.5%
Alkermes plc (ALKS)100107.8+7.8%
MicroCloud Hologram… (HOLO)1000.0-100.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: NNOX vs DBVT vs ALKS vs HOLO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HOLO leads in 3 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. DBV Technologies S.A. is the stronger pick specifically for recent price momentum and sentiment. ALKS also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
NNOX
Nano-X Imaging Ltd.
The Secondary Option

NNOX lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
DBVT
DBV Technologies S.A.
The Income Pick

DBVT is the #2 pick in this set and the best alternative if income & stability is your priority.

  • Dividend streak 0 yrs, beta 1.26
  • +110.4% vs HOLO's -78.7%
Best for: income & stability
ALKS
Alkermes plc
The Long-Run Compounder

ALKS is the clearest fit if your priority is long-term compounding and sleep-well-at-night.

  • -11.0% 10Y total return vs DBVT's -87.0%
  • Lower volatility, beta 1.06, Low D/E 3.8%, current ratio 3.55x
  • Beta 1.06, current ratio 3.55x
  • Beta 1.06 vs HOLO's 2.19
Best for: long-term compounding and sleep-well-at-night
HOLO
MicroCloud Hologram Inc.
The Growth Play

HOLO carries the broadest edge in this set and is the clearest fit for growth exposure.

  • Rev growth 42.6%, EPS growth 94.2%, 3Y rev CAGR -6.8%
  • 42.6% revenue growth vs DBVT's -100.0%
  • 91.9% margin vs NNOX's -452.8%
  • 10.0% ROA vs DBVT's -89.0%
Best for: growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthHOLO logoHOLO42.6% revenue growth vs DBVT's -100.0%
Quality / MarginsHOLO logoHOLO91.9% margin vs NNOX's -452.8%
Stability / SafetyALKS logoALKSBeta 1.06 vs HOLO's 2.19
DividendsTieNone of these 4 stocks pay a meaningful dividend
Momentum (1Y)DBVT logoDBVT+110.4% vs HOLO's -78.7%
Efficiency (ROA)HOLO logoHOLO10.0% ROA vs DBVT's -89.0%

NNOX vs DBVT vs ALKS vs HOLO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

NNOXNano-X Imaging Ltd.

Segment breakdown not available.

DBVTDBV Technologies S.A.

Segment breakdown not available.

ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
HOLOMicroCloud Hologram Inc.
FY 2024
Services
97.3%$282M
Products
2.7%$8M

NNOX vs DBVT vs ALKS vs HOLO — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLALKSLAGGINGDBVT

Income & Cash Flow (Last 12 Months)

ALKS leads this category, winning 4 of 6 comparable metrics.

ALKS and DBVT operate at a comparable scale, with $1.6B and $0 in trailing revenue. HOLO is the more profitable business, keeping 91.9% of every revenue dollar as net income compared to NNOX's -4.5%. On growth, ALKS holds the edge at +28.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricNNOX logoNNOXNano-X Imaging Lt…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcHOLO logoHOLOMicroCloud Hologr…
RevenueTrailing 12 months$12M$0$1.6B$321M
EBITDAEarnings before interest/tax-$46M-$112M$212M-$3M
Net IncomeAfter-tax profit-$56M-$168M$153M$295M
Free Cash FlowCash after capex-$47M-$151M$392M$47M
Gross MarginGross profit ÷ Revenue-98.8%+65.4%+24.2%
Operating MarginEBIT ÷ Revenue-4.7%+12.3%-1.1%
Net MarginNet income ÷ Revenue-4.5%+9.8%+91.9%
FCF MarginFCF ÷ Revenue-3.8%+25.1%+14.7%
Rev. Growth (YoY)Latest quarter vs prior year+13.7%+28.2%+24.0%
EPS Growth (YoY)Latest quarter vs prior year+8.7%+91.5%-4.1%+153.4%
ALKS leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

HOLO leads this category, winning 2 of 3 comparable metrics.
MetricNNOX logoNNOXNano-X Imaging Lt…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcHOLO logoHOLOMicroCloud Hologr…
Market CapShares × price$115M$1712.35T$5.9B$3M
Enterprise ValueMkt cap + debt − cash$83M$1712.35T$4.9B-$121M
Trailing P/EPrice ÷ TTM EPS-1.93x-0.76x24.76x-0.27x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple17.25x
Price / SalesMarket cap ÷ Revenue10.20x4.00x0.06x
Price / BookPrice ÷ Book value/share0.55x0.66x3.28x0.01x
Price / FCFMarket cap ÷ FCF12.28x
HOLO leads this category, winning 2 of 3 comparable metrics.

Profitability & Efficiency

ALKS leads this category, winning 5 of 9 comparable metrics.

HOLO delivers a 10.3% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-130 for DBVT. HOLO carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to DBVT's 0.13x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs HOLO's 3/9, reflecting strong financial health.

MetricNNOX logoNNOXNano-X Imaging Lt…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcHOLO logoHOLOMicroCloud Hologr…
ROE (TTM)Return on equity-35.5%-130.2%+8.8%+10.3%
ROA (TTM)Return on assets-31.6%-89.0%+5.4%+10.0%
ROICReturn on invested capital-27.9%+18.9%-27.3%
ROCEReturn on capital employed-28.4%-145.7%+14.2%-16.0%
Piotroski ScoreFundamental quality 0–94473
Debt / EquityFinancial leverage0.04x0.13x0.04x0.00x
Net DebtTotal debt minus cash-$32M-$172M-$1.0B-$844M
Cash & Equiv.Liquid assets$39M$194M$1.1B$851M
Total DebtShort + long-term debt$7M$22M$70M$8M
Interest CoverageEBIT ÷ Interest expense-379.29x-189.82x32.30x
ALKS leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — DBVT and ALKS each lead in 3 of 6 comparable metrics.

A $10,000 investment in ALKS five years ago would be worth $16,091 today (with dividends reinvested), compared to $0 for HOLO. Over the past 12 months, DBVT leads with a +110.4% total return vs HOLO's -78.7%. The 3-year compound annual growth rate (CAGR) favors DBVT at 6.2% vs HOLO's -95.1% — a key indicator of consistent wealth creation.

MetricNNOX logoNNOXNano-X Imaging Lt…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcHOLO logoHOLOMicroCloud Hologr…
YTD ReturnYear-to-date-37.8%+4.9%+25.3%-37.9%
1-Year ReturnPast 12 months-64.4%+110.4%+16.5%-78.7%
3-Year ReturnCumulative with dividends-89.2%+19.7%+14.5%-100.0%
5-Year ReturnCumulative with dividends-93.9%-69.1%+60.9%-100.0%
10-Year ReturnCumulative with dividends-96.1%-87.0%-11.0%-100.0%
CAGR (3Y)Annualised 3-year return-52.4%+6.2%+4.6%-95.1%
Evenly matched — DBVT and ALKS each lead in 3 of 6 comparable metrics.

Risk & Volatility

ALKS leads this category, winning 2 of 2 comparable metrics.

ALKS is the less volatile stock with a 1.06 beta — it tends to amplify market swings less than HOLO's 2.19 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 96.7% from its 52-week high vs HOLO's 14.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricNNOX logoNNOXNano-X Imaging Lt…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcHOLO logoHOLOMicroCloud Hologr…
Beta (5Y)Sensitivity to S&P 5001.86x1.26x1.06x2.19x
52-Week HighHighest price in past year$5.86$26.18$36.60$11.82
52-Week LowLowest price in past year$1.66$7.53$25.17$1.54
% of 52W HighCurrent price vs 52-week peak+30.0%+76.3%+96.7%+14.6%
RSI (14)Momentum oscillator 0–10038.548.160.243.3
Avg Volume (50D)Average daily shares traded1.4M252K2.3M722K
ALKS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: NNOX as "Buy", DBVT as "Buy", ALKS as "Buy". Consensus price targets imply 922.7% upside for NNOX (target: $18) vs 24.3% for ALKS (target: $44).

MetricNNOX logoNNOXNano-X Imaging Lt…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcHOLO logoHOLOMicroCloud Hologr…
Analyst RatingConsensus buy/hold/sellBuyBuyBuy
Price TargetConsensus 12-month target$18.00$46.33$44.00
# AnalystsCovering analysts51528
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises00
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+0.5%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

ALKS leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). HOLO leads in 1 (Valuation Metrics). 1 tied.

Best OverallAlkermes plc (ALKS)Leads 3 of 6 categories
Loading custom metrics...

NNOX vs DBVT vs ALKS vs HOLO: Key Questions Answered

8 questions · data-driven answers · updated daily

01

Is NNOX or DBVT or ALKS or HOLO a better buy right now?

For growth investors, MicroCloud Hologram Inc.

(HOLO) is the stronger pick with 42. 6% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). Alkermes plc (ALKS) offers the better valuation at 24. 8x trailing P/E, making it the more compelling value choice. Analysts rate Nano-X Imaging Ltd. (NNOX) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — NNOX or DBVT or ALKS or HOLO?

Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +60.

9%, compared to -100. 0% for MicroCloud Hologram Inc. (HOLO). Over 10 years, the gap is even starker: ALKS returned -11. 0% versus HOLO's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — NNOX or DBVT or ALKS or HOLO?

By beta (market sensitivity over 5 years), Alkermes plc (ALKS) is the lower-risk stock at 1.

06β versus MicroCloud Hologram Inc. 's 2. 19β — meaning HOLO is approximately 107% more volatile than ALKS relative to the S&P 500. On balance sheet safety, MicroCloud Hologram Inc. (HOLO) carries a lower debt/equity ratio of 0% versus 13% for DBV Technologies S. A. — giving it more financial flexibility in a downturn.

04

Which is growing faster — NNOX or DBVT or ALKS or HOLO?

By revenue growth (latest reported year), MicroCloud Hologram Inc.

(HOLO) is pulling ahead at 42. 6% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: MicroCloud Hologram Inc. grew EPS 94. 2% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Over a 3-year CAGR, NNOX leads at 105. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — NNOX or DBVT or ALKS or HOLO?

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus -474. 3% for Nano-X Imaging Ltd. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus -502. 9% for NNOX. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — NNOX or DBVT or ALKS or HOLO?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is NNOX or DBVT or ALKS or HOLO better for a retirement portfolio?

For long-horizon retirement investors, Alkermes plc (ALKS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

06)). MicroCloud Hologram Inc. (HOLO) carries a higher beta of 2. 19 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ALKS: -11. 0%, HOLO: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between NNOX and DBVT and ALKS and HOLO?

These companies operate in different sectors (NNOX (Healthcare) and DBVT (Healthcare) and ALKS (Healthcare) and HOLO (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: NNOX is a small-cap quality compounder stock; DBVT is a mega-cap quality compounder stock; ALKS is a small-cap quality compounder stock; HOLO is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

NNOX

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 6%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

HOLO

High-Growth Quality Leader

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 12%
  • Net Margin > 55%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.